Eli Lilly and Company

Eli Lilly and Company - PE Ratioverified

LLY

Price:

$1098.13

Market Cap:

$1.03T

Eli Lilly and Company is a prominent global pharmaceutical firm dedicated to the research, development, and commercialization of human medicines across the world. Its therapeutic offerings include a comprehensive suite of diabetes medications. This encompasses various insulin formulations like Basaglar, the Humalog family (e.g., Mix 75/25, U-100, U-200, Mix 50/50), insulin lispro products (including protamine and mix 75/25), and the Humulin line (e.g., 70/30, N, R, U-500). Furthermore, Eli Lilly provides specialized treatments for type 2 diabetes, such as Jardiance, Trajenta, and Trulicity. In oncology, Eli Lilly offers a robust portfolio targeting various cancers. These include Alimta for n...[Read more]

Industry

Drug Manufacturers - General

IPO Date

1972-06-01

Stock Exchange

NYSE

Ticker

LLY

The PE Ratio as of June 2026 (TTM) for Eli Lilly and Company (LLY) is 38.98

According to Eli Lilly and Company’s latest financial reports and current stock price. The company's current PE Ratio is 38.98. This represents a change of 24.08% compared to the average of 31.42 of the last 4 quarters.

Eli Lilly and Company (LLY) Historical PE Ratio (quarterly & annually)

How has LLY PE Ratio performed in the past?

The mean historical PE Ratio of Eli Lilly and Company over the last ten years is -2.17. The current 38.98 PE Ratio has changed -180093.85% with respect to the historical average. Over the past ten years (40 quarters), LLY's PE Ratio was at its highest in in the September 2024 quarter at 205.08. The PE Ratio was at its lowest in in the September 2023 quarter at -2219.55.

Quarterly (TTM)
Annual

Average

-2.17

Median

41.79

Minimum

-444.53

Maximum

99.99

Eli Lilly and Company (LLY) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Eli Lilly and Company PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 80.94%

Maximum Annual PE Ratio = 99.99

Minimum Annual Increase = -1604.92%

Minimum Annual PE Ratio = -444.53

Quarterly (TTM)
Annual
YearPE RatioChange
202546.73-28.82%
202465.65-34.34%
202399.9979.56%
202255.6817.93%
202147.2280.94%
202026.1072.54%
201915.12-58.96%
201836.85-108.29%
2017-444.53-1604.92%
201629.54-23.58%

Eli Lilly and Company (LLY) Average PE Ratio

How has LLY PE Ratio performed in the past?

The current PE Ratio of Eli Lilly and Company (LLY) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

3-year avg

70.79

5-year avg

63.05

10-year avg

-2.17

Eli Lilly and Company (LLY) PE Ratio vs. Peers

How is LLY’s PE Ratio compared to its peers?

Eli Lilly and Company’s PE Ratio is greater than Johnson & Johnson (26.34), greater than AstraZeneca PLC (25.98), less than AbbVie Inc. (106.22), greater than Novartis AG (21.02), greater than Amgen Inc. (23.31), greater than Novo Nordisk A/S (10.68), greater than Merck & Co., Inc. (31.99), greater than Gilead Sciences, Inc. (16.68), greater than Pfizer Inc. (19.25), greater than Sanofi (11.75),

CompanyPE RatioMarket cap
26.34$549.78B
25.98$271.29B
106.22$382.74B
21.02$280.64B
23.31$182.21B
10.68$191.93B
31.99$281.24B
16.68$153.66B
19.25$143.74B
11.75$101.89B

Build a custom stock screener for Eli Lilly and Company (LLY) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Eli Lilly and Company using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Eli Lilly and Company (LLY) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Eli Lilly and Company or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Eli Lilly and Company's PE Ratio?

How is the PE Ratio calculated for Eli Lilly and Company (LLY)?

What is the highest PE Ratio for Eli Lilly and Company (LLY)?

What is the 3-year average PE Ratio for Eli Lilly and Company (LLY)?

What is the 5-year average PE Ratio for Eli Lilly and Company (LLY)?

How does the current PE Ratio for Eli Lilly and Company (LLY) compare to its historical average?